Immix Biopharma, Inc.
We are a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics (“TSTx”)TM in oncology and inflammation.
$5.00 - $6.00
December 16, 2021
FORDHAM FINANCIAL MANAGEMENT, INC.
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Immix Biopharma, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277